The Med-Tech company PolarCool AB (publ.) has signed a two-year agreement with the English Championship rugby team Cambridge Rugby Club for the use of the PolarCap® System. This marks the company’s second agreement in the UK’s second-tier of professional rugby.

The agreement with Cambridge Rugby Club represents another important step for PolarCool in the English Championship, highlighting a growing commitment to enhancing player safety in English rugby. PolarCool has previously secured a similar agreement with league counterparts Doncaster Knights.

PolarCool CEO Erik Andersson comments;

-We are pleased with our continued expansion within English rugby and the growing interest we have across multiple leagues. This agreement demonstrates the applicability of the PolarCap® System as a treatment method and underscores our commitment to player safety and health. We are excited to partner with Cambridge Rugby to deliver effective and immediate treatment for players experiencing concussions.

Cambridge Rugby Club boasts a storied history, as one of the oldest rugby clubs in England. In 2023, Cambridge achieved promotion to the English Championship, marking a significant milestone for the team. The agreement with Cambridge Rugby is strategically important for PolarCool, even though the financial impact of individual contracts is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.